Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 74.92% is in line with its 5-year average of 73.09%, near the high end of its 5-year range (35.07%–87.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.88% above its 12-month average of 74.27%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 74.92%.
DEBT TO ASSETS RATIO
74.92%
DEBT TO ASSETS RATIO AVG TTM
74.27%
DEBT TO ASSETS RATIO AVG 3Y
70.42%
DEBT TO ASSETS RATIO AVG 5Y
73.09%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.88%
CURRENT VS 3Y AVG
+6.40%
CURRENT VS 5Y AVG
+2.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 810 covered companies
CURRENT VS SECTOR MEDIAN
+83147.93%
vs the sector median at left
Establishment Labs Holdings Inc.
Market Cap
$1.92B
Debt to Assets Ratio
74.92%
TTM Avg
74.27%
3Y Avg
70.42%
5Y Avg
73.09%
Market Cap
$1.95B
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.98B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.85B
Debt to Assets Ratio
0.43%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.92B | 74.92% | 74.27% | 70.42% | 73.09% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.95B | 0.15% | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | 0.03% | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $1.96B | 0.07% | N/A | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $1.89B | 0.01% | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 0.04% | N/A | N/A | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.98B | 0.03% | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 0.43% | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $1.84B | 0.03% | N/A | N/A | N/A |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 0.00% | N/A | N/A | N/A |
Debt/Assets
74.9%
Debt/Equity
12.20
Current Ratio
3.84
Interest Coverage
-1.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 74.92% |
| 2026-03-31 | 75.19% |
| 2025-12-31 | 74.05% |
| 2025-09-30 | 77.06% |
| 2025-06-30 | 70.11% |
| 2025-03-31 | 67.70% |
| 2024-12-31 | 64.96% |
| 2024-09-30 | 70.51% |
| 2024-06-30 | 69.30% |
| 2024-03-31 | 65.00% |
| 2023-12-31 | 71.55% |
| 2023-09-30 | 69.86% |
| 2023-06-30 | 65.19% |
| 2023-03-31 | 87.34% |
| 2022-12-31 | 84.97% |
| 2022-09-30 | 81.04% |
| 2022-06-30 | 73.85% |
| 2022-03-31 | 38.64% |
| 2021-12-31 | 38.85% |
| 2021-09-30 | 36.23% |
| 2021-06-30 | 35.07% |
| 2021-03-31 | 34.81% |
| 2020-12-31 | 33.60% |
| 2020-09-30 | 31.95% |
| 2020-06-30 | 31.28% |
| 2020-03-31 | 28.92% |
| 2019-12-31 | 41.53% |
| 2019-09-30 | 40.40% |
| 2019-06-30 | 23.29% |
| 2019-03-31 | 21.28% |
| 2018-12-31 | 19.15% |
| 2018-09-30 | 17.69% |
| 2018-06-30 | 40.66% |
| 2018-03-31 | 42.20% |
| 2017-12-31 | 42.19% |
